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Portuguese Prevalence of Pediatric
Chronic Intestinal Failure
T o the Editor: Intestinal failure (IF) is defined as the inabilityof the gut to absorb sufficient water, macronutrients (carbo-
hydrate, protein, and fat), micronutrients, and electrolytes, and thus
a requirement of intravenous supplementation or replacement in
order to sustain life (1). Short bowel syndrome is the most common
cause of IF (2). A pediatric review dated of 2012, from Germany,
reported that the prevalence of chronic IF (CIF) in children is 13.7
per million (3).
The condition is incompatible with life in the absence of the
safe application of specialized and individualized medical therapy
(4). Long-term home parenteral nutrition (PN) has dramatically
improved the life expectancy and quality of life in children with
CIF. The considerable costs, however, of PN bags and burden of
necessary-associated healthcare, such as central venous catheters,
with consequent risks of infection and thrombosis, should not be
dismissed. New drugs or treatment strategies are essential for
these patients.
In order to be registered in a database to benefit from clinical
trials and new treatment strategies, the Portuguese Pediatric Gas-
troenterology, Hepatology and Nutrition Society (SPGP) proposed
this Pediatric CIF multicenter study. In December 2018, all units
responsible for the follow-up of all Portuguese children with CIF
met in the first national CIF meeting of SPGP. The aim of the
meeting was to enable the pediatric national multicenter group to
increase knowledge of the field and share their experiences as well
as to merge their data, including to determine the prevalence of CIF
in Portuguese children, which had been unknown until recently. The
newly developed database identified 51 children/adolescents (under
18 years of age) requiring PN in order to live because of CIF with a
male to female ratio of 1.1 : 1. Using data from the National
Statistics Institute in 2018, Portugal had 1 960 310 inhabitants less
than 18 years old. Therefore, the data suggested a prevalence of CIF
in Portugal of 27 patients per million inhabitants younger than
18 years.
The majority of the 51 patients had short bowel syndrome
(n¼ 38). The most frequent cause for short bowel syndrome was
intestinal volvulus (16) followed by congenital intestinal atresia
(11), gastroschisis (6), and necrotizing enterocolitis (5). Ages
ranged from 3 months to 17 years old. At the time of submission
of this letter, all but 2 of the children remained on PN with partial
enteral nutrition. Six paediatric patients were still in the hospital
(1 for social reasons). Seven patients started teduglutide
during 2019 resulting in 2 discontinuing PN and the remaining
reducing their requirement for PN (1 reducing the frequency to
4 days/week and 2–3 days/week as well as 2 reducing the daily
PN volume).
The remainder of the 51 patients had chronic intestinal
pseudo-obstruction (6), Hirschsprung disease (2), Mitchell Riley
syndrome (2); very early onset Inflammatory Bowel Disease
(VEOIBD) with Interleukin 10 receptor and Syntaxin-Binding
Protein 3 deficiency (2) and Ewing sarcoma (1). Both children
with VEOIBD have subsequently had haematopoietic stem cell
transplantation, of which one recently came off PN but the other
died. The child with the Ewing Sarcoma suffered an intestinal
obstruction with peritonitis and sepsis requiring intestinal resection
and although he had more than 60 cm of residual small intestine
continued to need PN.
Our data provides the first ever data about the prevalence of
CIF and associated PN use in Portugal. It allows the SPGP to
compare these data with other European countries and provides the
opportunity to improve the medical care and quality of life for
Portuguese patients and their families. Finally, it provides the
Portuguese government a tool to develop a future strategy to deal
with this complex medical condition.
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Two Novel PNLIP Mutations Causing
Congenital Lipase Deficiency in
Identical Twin Boys
T o the Editor: Congenital pancreatic enzyme deficiencies arerare causes of exocrine pancreatic insufficiency in children.
There is only 1 described mutation in the pancreatic lipase gene,
PNLIP, reported in the literature. In 2014, Behar et al (1) described a
homozygous missense mutation at amino acid 221 in PNLIP
causing congenital lipase deficiency in 2 brothers of consangui-
neous parents. In 2015, the mutation was studied in cellular and
LETTERS TO THE EDITOR
JPGN  Volume 70, Number 4, April 2020 e85
